Martius flaps for low rectovaginal fistulae: a systematic review and proportional meta-analysis

Daisy Swindon1, Sara Izwan1, Justin Ng1

  • 1Department of Colorectal Surgery, Gold Coast University Hospital, Gold Coast, Queensland, Australia.

ANZ Journal of Surgery
|March 13, 2024
PubMed
Abstract

Insights

The Martius flap (MF) shows higher success rates for primary rectovaginal fistulae (RVF) than recurrent ones. However, more randomized studies are needed to confirm these findings due to data limitations.

Area of Science:

  • Surgical techniques
  • Gastroenterology
  • Gynecologic surgery

Background:

  • Rectovaginal fistulae (RVF) present significant treatment challenges.
  • The Martius flap (MF) is one surgical option for RVF management, but its universal success is not established.

Purpose of the Study:

  • To assess the outcomes of rectovaginal fistulae managed with Martius flap interposition.
  • To determine the mean success rate, complication rate, and recurrence rate of MF for RVF.

Main Methods:

  • A PRISMA-compliant meta-analysis was conducted on studies reporting MF outcomes for RVF.
  • Proportional meta-analyses were performed using MedCalc software.
  • Weighted mean values and 95% confidence intervals were calculated and stratified by etiology.

Main Results:

  • Twelve non-randomized studies involving 137 Martius flaps were analyzed.
  • The weighted mean success rate was 91.4% for primary RVF and 77.5% for recurrent RVF.
  • The overall complication rate was 29% and the recurrence rate was 12.0%.

Conclusions:

  • Martius flap interposition demonstrates higher efficacy in treating primary RVF compared to recurrent RVF.
  • The current evidence is limited by data quality, necessitating further investigation with randomized controlled trials.